Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (41-50 of 578) with videos related to

Pageof 58
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Reply to B. Freidlin et alIgnace Vergote, Corneel Coens, Antonio Casado, et al.
Current Oncology Reports|October 3, 2003
The role of interval debulking surgery in ovarian cancerMaria E L van der Burg, Ignace Vergote,
The Lancet. Oncology|April 4, 2009
Screening for ovarian carcinoma: not quite there yetIgnace Vergote, Frédéric Amant, Lieveke Ameye, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 23, 2006
Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case reportSophie Marquette, Frederic Amant, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2002
Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancerIgnace Vergote, F Amant, P Berteloot, et al.
Critical Reviews in Oncology/Hematology|February 26, 2008
Gynecologic oncology in pregnancyFrédéric Amant, Kristel Van Calsteren, Ignace Vergote, et al.
Gynecologic Oncology|December 22, 2010
The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010)Chyong-Huey Lai, Angel Chao, Frederic Amant, et al.
Basic & Clinical Pharmacology & Toxicology|March 6, 2018
ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer PatientsNiclas Björn, Ingrid Jakobsen Falk, Ignace Vergote, et al.
Journal of the Society for Gynecologic Investigation|November 8, 2006
Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspringSuzan Lambin, Rita van Bree, Ignace Vergote, et al.
Lancet (London, England)|March 27, 2019
Epithelial ovarian cancerStephanie Lheureux, Charlie Gourley, Ignace Vergote, et al.
Pageof 58

Showing results (41-50 of 578) with videos related to

Sort By:
Pageof 58
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Reply to B. Freidlin et alIgnace Vergote, Corneel Coens, Antonio Casado, et al.
Current Oncology Reports|October 3, 2003
The role of interval debulking surgery in ovarian cancerMaria E L van der Burg, Ignace Vergote,
The Lancet. Oncology|April 4, 2009
Screening for ovarian carcinoma: not quite there yetIgnace Vergote, Frédéric Amant, Lieveke Ameye, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 23, 2006
Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case reportSophie Marquette, Frederic Amant, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2002
Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancerIgnace Vergote, F Amant, P Berteloot, et al.
Critical Reviews in Oncology/Hematology|February 26, 2008
Gynecologic oncology in pregnancyFrédéric Amant, Kristel Van Calsteren, Ignace Vergote, et al.
Gynecologic Oncology|December 22, 2010
The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010)Chyong-Huey Lai, Angel Chao, Frederic Amant, et al.
Basic & Clinical Pharmacology & Toxicology|March 6, 2018
ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer PatientsNiclas Björn, Ingrid Jakobsen Falk, Ignace Vergote, et al.
Journal of the Society for Gynecologic Investigation|November 8, 2006
Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspringSuzan Lambin, Rita van Bree, Ignace Vergote, et al.
Lancet (London, England)|March 27, 2019
Epithelial ovarian cancerStephanie Lheureux, Charlie Gourley, Ignace Vergote, et al.
Pageof 58